The chromatin-remodeling enzyme BRG1 modulates vascular Wnt signaling at two levels

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 6, 2011, Pages 2282-2287

  Griffin, Courtney T ^a,b   Curtis, Carol D ^a   Davis, Reema B ^a,b   Muthukumar, Vijay ^a   Magnuson, Terry ^c  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Frizzled receptor; Lithium chloride; SWItch Sucrose NonFermentable

Indexed keywords

BETA CATENIN; BRG1 PROTEIN; LITHIUM CHLORIDE; WNT PROTEIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; CHROMATIN STRUCTURE; DOWN REGULATION; EMBRYO DEVELOPMENT; EPIGENETICS; FEMALE; GENE DELETION; GENE TARGETING; GENETIC TRANSFECTION; MODULATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; RECEPTOR GENE; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM; WESTERN BLOTTING; YOLK SAC;

ANIMALS; CELL LINE; DNA HELICASES; DOWN-REGULATION; EMBRYO, MAMMALIAN; EMBRYONIC DEVELOPMENT; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EPIGENESIS, GENETIC; FRIZZLED RECEPTORS; GENE DELETION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MICE; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; NUCLEAR PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; WNT PROTEINS;

EID: 79952285950     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1013751108     Document Type: Article

References (39)

1. Becker PB, Hörz W (2002) ATP-dependent nucleosome remodeling. Annu Rev Biochem 71:247-273. (Pubitemid 34800221)
2. Smith CL, Peterson CL (2005) ATP-dependent chromatin remodeling. Curr Top Dev Biol 65:115-148.
3. Ho L, Crabtree GR (2010) Chromatin remodelling during development. Nature 463:474-484.
4. Kwon CS, Wagner D (2007) Unwinding chromatin for development and growth: A few genes at a time. Trends Genet 23:403-412. (Pubitemid 47088011)
5. Ho L, et al. (2009) An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency. Proc Natl Acad Sci USA 106:5181-5186.
6. Lessard J, et al. (2007) An essential switch in subunit composition of a chromatin remodeling complex during neural development. Neuron 55:201-215. (Pubitemid 47048906)
7. Takeuchi JK, Bruneau BG (2009) Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors. Nature 459:708-711.
8. Wu JI, et al. (2007) Regulation of dendritic development by neuron-specific chromatin remodeling complexes. Neuron 56:94-108. (Pubitemid 47484177)
9. Mohrmann L, Verrijzer CP (2005) Composition and functional specificity of SWI2/SNF2 class chromatin remodeling complexes. Biochim Biophys Acta 1681:59-73. (Pubitemid 41071379)
10. Sudarsanam P, Winston F (2000) The Swi/Snf family nucleosome-remodeling complexes and transcriptional control. Trends Genet 16:345-351. (Pubitemid 30628835)
11. Bultman S, et al. (2000)ABrg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol Cell 6:1287-1295. (Pubitemid 32045922)
12. Bultman SJ, et al. (2006) Maternal BRG1 regulates zygotic genome activation in the mouse. Genes Dev 20:1744-1754. (Pubitemid 43992883)
13. Bultman SJ, Gebuhr TC, Magnuson T (2005) A Brg1 mutation that uncouples ATPase activity from chromatin remodeling reveals an essential role for SWI/SNF-related complexes in beta-globin expression and erythroid development. Genes Dev 19:2849-2861. (Pubitemid 41739970)
14. Gebuhr TC, et al. (2003) The role of Brg1, a catalytic subunit of mammalian chromatin-remodeling complexes, in T cell development. J Exp Med 198:1937-1949. (Pubitemid 38032125)
15. Hang CT, et al. (2010) Chromatin regulation by Brg1 underlies heart muscle development and disease. Nature 466:62-67.
16. Griffin CT, Brennan J, Magnuson T (2008) The chromatin-remodeling enzyme BRG1 plays an essential role in primitive erythropoiesis and vascular development. Development 135:493-500.
17. Stankunas K, et al. (2008) Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis. Dev Cell 14:298-311. (Pubitemid 351189176)
18. Cohen ED, Tian Y, Morrisey EE (2008) Wnt signaling: An essential regulator of cardiovascular differentiation, morphogenesis and progenitor self-renewal. Development 135:789-798. (Pubitemid 351524132)
19. Goodwin AM, D'Amore PA (2002) Wnt signaling in the vasculature. Angiogenesis 5:1-9. (Pubitemid 36076918)
20. Zerlin M, Julius MA, Kitajewski J (2008) Wnt/Frizzled signaling in angiogenesis. Angiogenesis 11:63-69.
21. MacDonald BT, Tamai K, He X (2009) Wnt/beta-catenin signaling: Components, mechanisms, and diseases. Dev Cell 17:9-26.
22. Corada M, et al. (2010) The Wnt/beta-catenin pathway modulates vascular remodeling and specification by upregulating Dll4/Notch signaling. Dev Cell 18:938-949.
23. Ishikawa T, et al. (2001) Mouse Wnt receptor gene Fzd5 is essential for yolk sac and placental angiogenesis. Development 128:25-33. (Pubitemid 32094383)
24. Cattelino A, et al. (2003) The conditional inactivation of the beta-catenin gene in endothelial cells causes a defective vascular pattern and increased vascular fragility. J Cell Biol 162:1111-1122. (Pubitemid 37174193)
25. Liebner S, et al. (2008) Wnt/beta-catenin signaling controls development of the blood-brain barrier. J Cell Biol 183:409-417.
26. Phng LK, et al. (2009) Nrarp coordinates endothelial Notch and Wnt signaling to control vessel density in angiogenesis. Dev Cell 16:70-82.
27. Wang SJ, Greer P, Auerbach R (1996) Isolation and propagation of yolk-sac-derived endothelial cells from a hypervascular transgenic mouse expressing a gain-of-function fps/fes proto-oncogene. In Vitro Cell Dev Biol Anim 32:292-299.
28. Rudini N, Dejana E (2008) Adherens junctions. Curr Biol 18:R1080-R1082.
29. van Noort M, Meeldijk J, van der Zee R, Destree O, Clevers H (2002) Wnt signaling controls the phosphorylation status of beta-catenin. J Biol Chem 277:17901-17905. (Pubitemid 34967600)
30. Goodwin AM, Sullivan KM, D'Amore PA (2006) Cultured endothelial cells display endogenous activation of the canonical Wnt signaling pathway and express multiple ligands, receptors, and secreted modulators of Wnt signaling. Dev Dyn 235:3110-3120. (Pubitemid 44749701)
31. Tian Y, et al. (2010) Characterization and in vivo pharmacological rescue of a Wnt2-Gata6 pathway required for cardiac inflow tract development. Dev Cell 18:275-287.
32. Barker N, et al. (2001) The chromatin remodelling factor Brg-1 interacts with beta-catenin to promote target gene activation. EMBO J 20:4935-4943. (Pubitemid 32848645)
33. Park JI, et al. (2009) Telomerase modulates Wnt signalling by association with target gene chromatin. Nature 460:66-72.
34. Daneman R, et al. (2009) Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis. Proc Natl Acad Sci USA 106:641-646.
35. Stenman JM, et al. (2008) Canonical Wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature. Science 322:1247-1250.
36. Dejana E (2004) Endothelial cell-cell junctions: Happy together. Nat Rev Mol Cell Biol 5:261-270.
37. Chen Y, et al. (2009) Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models. Am J Pathol 175:2676-2685.
38. Kisanuki YY, et al. (2001) Tie2-Cre transgenic mice: A new model for endothelial cell-lineage analysis in vivo. Dev Biol 230:230-242. (Pubitemid 32171420)
39. Maretto S, et al. (2003) Mapping Wnt/beta-catenin signaling during mouse development and in colorectal tumors. Proc Natl Acad Sci USA 100:3299-3304. (Pubitemid 36356577)